Life is Full of Opportunities...
Preserving cord blood stem cells may hold promising opportunities for the future. Currently, many diseases, including a wide range of cancers, genetic diseases, blood disorders, and immune system deficiencies can be treated with umbilical cord blood stem cells. And we've only seen the tip of the iceberg-results from ongoing research may change the way many other diseases are treated and cured in the coming years.
Take advantage of this chance to invest in your family's future and preserve your baby's umbilical cord blood stem cells with MiraCell. It is a decision that may give your child, or someone else in your family, the opportunity of a lifetime.
What are Stem Cells?
Stem cells are essential master cells from which other cells are created. They are often referred to as "building blocks" of the body's blood and immune system and can grow into other specific cell types that make up organs, muscles and nerves.
Stem cells are found in various parts of the body, such as bone marrow, circulating blood in the body (peripheral blood), and also umbilical cord blood (UCB). These types of cells are called hematopoietic stem cells (HSC).
Currently, over 60 different diseases have been treated with stem cell transplantation, including a wide range of cancers, genetic diseases, blood disorders, and immune system deficiencies;* and, the future looks even more promising. Transplant science has evolved rapidly over the last decade and research has found that stem cells may someday help cure many more diseases. The use of stem cells is being studied in life-threatening conditions, such as heart disease, stroke, diabetes, Parkinson's disease, Alzheimer's disease and others.
Cord Blood Stem Cells vs. Bone Marrow Stem Cells
UCB stem cells have significant advantages over those found in bone marrow, both in collection and transplantation
- Less Time, No Risk - Obtaining UCB stem cells poses no risk to the mother or child, is painless, and takes only minutes to collect, unlike collecting bone marrow stem cells, which is painful to the donor and time consuming.
- Better Stem Cell Yield - UCB contains 10-20% more stem cells than bone marrow. UCB stem cells are also of higher quality than those in bone marrow.
- Perfect Match - Finding a perfect HLA match of bone marrow stem cells can be difficult, if not impossible, and can be a lengthy process. Preserving UCB stem cells ensures that your baby has a perfect HLA match that can be accessed immediately if needed. These same stem cells hold a 25% or greater chance of being suitable for transplant in a sibling, and potentially beneficial to an immediate family member.
- Less Incidence of Rejection - Graft versus host disease (GVHD) is a condition where donor stem cells recognize the transplant recipient's body, or the "host," as foreign. The stem cells then build antibodies against the host. GVHD is more prevalent in bone marrow stem cell recipients. When transplanting the UCB stem cells back into the donating child, (autologous transplant) GVHD is not a concern due to a perfect HLA match. With a
sibling child, statistics indicate very low GVHD is encountered.
- Cost Effective - UCB stem cell transplants are far less costly than bone marrow transplants.
* While umbilical cord blood technology holds promise with respect to the treatment of various diseases, the
technology is experimental in nature. Although the potential use of umbilical cord blood is expanding rapidly, the odds
that a family without a defined risk will require the use of their child's umbilical cord blood are low. Furthermore, there is no guarantee
that the umbilical cord blood will be a match to a family member. As with any transplant therapy, therapeutic success depends upon many factors beyond the stem cells themselves including patient condition, type of disease, recipient-donor relationship and matching.